The superconducting
technology of
CYCLOMED's compact
cyclotron offers great
advantages in nuclear
medicine

The superconducting
technology of
CYCLOMED's compactcyclotron offers great
advantages in nuclear medicine

The main advantages of the CYCLOMED
cyclotron
are:
Reduced weight
and size
The cyclotron has been manufactured using superconducting magnets, which has allowed a much more compact design that allows cost savings in transport and installation.
Lower energy consumption and less need for radiation protection
This reduction in its dimensions and the possibility of being self-shielded, allows the cyclotron to be installed without the need to build a bunker, which considerably reduces the civil works costs associated with the installation.
Reduced weight and size
The cyclotron has been manufactured using superconducting magnets, which has allowed a much more compact design that allows cost savings in transport and installation.
Lower energy consumption and less need for radiation protection
This reduction in its dimensions and the possibility of being self-shielded, allows the cyclotron to be installed without the need to build a bunker, which considerably reduces the civil works costs associated with the installation.
Reduction in cooling time
The superconducting magnets of this cyclotron work at temperatures of the order of 5 K (-268 ºC). The configuration proposed for these magnets, together with the cooling system, makes it possible to reduce cooling time by 80% of that required in other cyclotrons and, therefore, ensures the operation of the equipment in a much shorter time.
Single-dose production
The design of the CYCLOMED cyclotron allows production on demand and on site, without having to depend on long planning and waiting times. This is a significant advantage in nuclear medicine, for both the patient and the radiopharmaceutical producer, as it allows them to optimise and adapt the production of a highly perishable product to specific situations of demand that may vary in an unexpected way.
Reduction in cooling time
The superconducting magnets of this cyclotron work at temperatures of the order of 5 K (-268 ºC). The configuration proposed for these magnets, together with the cooling system, makes it possible to reduce cooling time by 80% of that required in other cyclotrons and, therefore, ensures the operation of the equipment in a much shorter time.
Single-dose production
The design of the CYCLOMED cyclotron allows production on demand and on site, without having to depend on long planning and waiting times. This is a significant advantage in nuclear medicine, for both the patient and the radiopharmaceutical producer, as it allows them to optimise and adapt the production of a highly perishable product to specific situations of demand that may vary in an unexpected way.
Possibility of exploiting very short life radiopharmaceuticals
The use of this cyclotron model allows the synthesis of very short half-life radioisotopes such as
Carbon-11 and Fluorine-18. These positron-emitting radioactive isotopes act as molecular probes that allow the expansion of knowledge of biochemical processes and diagnostic methods that are key to mitigate diseases of global concern such as neurological, oncological and cardiovascular diseases.
Possibility of exploiting very short life radiopharmaceuticals
The use of this cyclotron model allows the synthesis of very short half-life radioisotopes such as Carbon-11 and Fluorine-18. These positron-emitting radioactive isotopes act as molecular probes that allow the expansion of knowledge of biochemical processes and diagnostic methods that are key to mitigate diseases of global concern such as neurological, oncological and cardiovascular diseases.